SE461892B - Oljeloeslig komposition av vitamin b -butyrat - Google Patents
Oljeloeslig komposition av vitamin b -butyratInfo
- Publication number
- SE461892B SE461892B SE8301565A SE8301565A SE461892B SE 461892 B SE461892 B SE 461892B SE 8301565 A SE8301565 A SE 8301565A SE 8301565 A SE8301565 A SE 8301565A SE 461892 B SE461892 B SE 461892B
- Authority
- SE
- Sweden
- Prior art keywords
- oil
- vitamin
- butyrate
- fatty acid
- fifi
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
- A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
- A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
- A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Public Health (AREA)
- Engineering & Computer Science (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Oil, Petroleum & Natural Gas (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Molecular Biology (AREA)
- Nutrition Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Biochemistry (AREA)
- Hematology (AREA)
- Obesity (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP57091466A JPS58208215A (ja) | 1982-05-31 | 1982-05-31 | 脂溶性ビタミン配合油溶組成物 |
Publications (3)
Publication Number | Publication Date |
---|---|
SE8301565D0 SE8301565D0 (sv) | 1983-03-22 |
SE8301565L SE8301565L (sv) | 1983-12-01 |
SE461892B true SE461892B (sv) | 1990-04-09 |
Family
ID=14027151
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SE8301565A SE461892B (sv) | 1982-05-31 | 1983-03-22 | Oljeloeslig komposition av vitamin b -butyrat |
Country Status (6)
Country | Link |
---|---|
JP (1) | JPS58208215A (de) |
CH (1) | CH656531A5 (de) |
DE (1) | DE3311008C2 (de) |
FR (1) | FR2527440B1 (de) |
GB (1) | GB2120935B (de) |
SE (1) | SE461892B (de) |
Families Citing this family (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5639724A (en) | 1984-07-24 | 1997-06-17 | Sandoz Ltd. | Cyclosporin galenic forms |
JPS63130535A (ja) * | 1986-11-19 | 1988-06-02 | Nisshin Kagaku Kk | 経口投与用抗ヒスタミン剤 |
US7081445B2 (en) | 1989-02-20 | 2006-07-25 | Novartis Ag | Cyclosporin galenic forms |
GB9325445D0 (en) | 1993-12-13 | 1994-02-16 | Cortecs Ltd | Pharmaceutical formulations |
GB2335854B (en) | 1997-01-30 | 2001-04-25 | Novartis Ag | Oil-free pharmaceutical compositions containing cyclosporin A |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
FR8014M (de) * | 1968-01-09 | 1970-07-27 | ||
US3962436A (en) * | 1969-06-03 | 1976-06-08 | Sumitomo Chemical Company, Limited | Pharmaceutical compositions having controlled rate of gastro-intestinal absorption |
NL7012460A (de) * | 1970-08-22 | 1972-02-24 | ||
US3932634A (en) * | 1973-06-28 | 1976-01-13 | Pfizer Inc. | High potency vitamin water dispersible formulations |
-
1982
- 1982-05-31 JP JP57091466A patent/JPS58208215A/ja active Granted
-
1983
- 1983-03-18 GB GB08307543A patent/GB2120935B/en not_active Expired
- 1983-03-22 SE SE8301565A patent/SE461892B/sv not_active IP Right Cessation
- 1983-03-25 CH CH1664/83A patent/CH656531A5/de not_active IP Right Cessation
- 1983-03-25 DE DE3311008A patent/DE3311008C2/de not_active Expired
- 1983-03-30 FR FR8305239A patent/FR2527440B1/fr not_active Expired
Also Published As
Publication number | Publication date |
---|---|
SE8301565L (sv) | 1983-12-01 |
SE8301565D0 (sv) | 1983-03-22 |
JPH044299B2 (de) | 1992-01-27 |
GB8307543D0 (en) | 1983-04-27 |
DE3311008C2 (de) | 1986-04-10 |
JPS58208215A (ja) | 1983-12-03 |
CH656531A5 (de) | 1986-07-15 |
GB2120935B (en) | 1985-10-23 |
FR2527440A1 (fr) | 1983-12-02 |
FR2527440B1 (fr) | 1987-05-15 |
DE3311008A1 (de) | 1983-12-01 |
GB2120935A (en) | 1983-12-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Thompson | A biochemical approach to the problem of multiple sclerosis | |
Rosenman et al. | Behavior patterns, blood lipids, and coronary heart disease | |
JP2677554B2 (ja) | 乾燥した微粒子のさらさらした安定なトコフエロール | |
Williams | Quick test for comparing two populations with bivariate data | |
DE60018372T2 (de) | Oralzusammensetzung als mikroemulsion von silybin | |
Woodall et al. | Nutrition of salmonoid fishes: XIII. The α-tocopherol requirement of Chinook salmon | |
Yang et al. | Effect of high levels of dietary vitamin E on liver and plasma lipids and fat soluble vitamins in rats | |
KR840005339A (ko) | 지용성물질을 함유한 수용액의 제조방법 | |
DE69723671T2 (de) | Cyclosüporin formulierung | |
GB1386260A (en) | Shortening for highly aerated creamy frostings | |
EP0196085B1 (de) | Ubidecarenon enthaltende Mittel mit erhöhter Absorption | |
Kattner et al. | Lipid composition of some typical North Sea copepods | |
SE461892B (sv) | Oljeloeslig komposition av vitamin b -butyrat | |
Stanley-Samuelson et al. | Arachidonic and other tissue fatty acids of Culex pipiens reared with various concentrations of dietary arachidonic acid | |
Lawrence et al. | An incident of elevated levels of unsaturated free fatty acids in mussels from Nova Scotia and their toxic effect in mice after intraperitoneal injection | |
Noble et al. | Metabolism of the yolk phospholipids by the developing chick embryo | |
SI9720010B (sl) | Ciklosporin vsebujoči mehki kapsulni pripravki | |
Gallo‐Torres et al. | Distribution and metabolism of two orally administered esters of tocopherol | |
Brooks et al. | Effects of air, ozone, and nitrogen dioxide exposure on the oxidation of corn and soybean lipids | |
Saldanha | Race mixture among northeastern Brazilian populations | |
KR102414627B1 (ko) | 효과적인 토코트리에놀 전달을 위한 제형 | |
US2895878A (en) | Compositions containing stabilized vitamin a materials | |
Yuan et al. | Comparative analysis of essential bioactive components of oils originating from three Chinese Loess Plateau wild crops | |
Tusing et al. | The chronic dermal toxicity of a series of polyethylene glycols | |
Mosbah et al. | Antioxidant and anti-hemolitic activities of Algerian Nigella sativa total oil and its neutral lipid fraction |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
NAL | Patent in force |
Ref document number: 8301565-1 Format of ref document f/p: F |
|
NUG | Patent has lapsed |